Rationale and design for the controlled ONset Verapamil INvestigation of cardiovascular endpoints (CONVINCE) trial

Henry R. Black, William J. Elliott, James D. Neaton, Gregory Grandits, Patricia Grambsch, Richard H. Grimm, Lennart Hansson, Yves Lacoucière, James Muller, Peter Sleight, Michael A. Weber, William B. White, Gordon Williams, Janet Wittes, Alberto Zanchetti, T. Daniel Fakouhi